文献速递免疫规划慢病防控与筛查

幼年特发性关节炎患者蜱传脑炎疫苗接种的体液与细胞免疫应答取决于加强针次

Humoral and cellular immune response to tick-borne-encephalitis (TBE) vaccination depends on booster doses in patients with Juvenile Idiopathic Arthritis (JIA).
PubMed 文献 · Vaccine · 2021-08-27

该研究比较了既往接种过蜱传脑炎疫苗的幼年特发性关节炎(JIA)患者与健康对照的体液和细胞免疫应答,发现两组IgG抗体浓度、中和滴度和细胞反应性相似;加强接种的次数和早期时机对JIA患者中和抗体及两组IgG浓度影响最大,TNF-α抑制剂对体液免疫有正面作用而甲氨蝶呤有负面作用。结论强调JIA患者及时接种加强针的必要性,且免疫抑制方案下接种仍高度可行。

要点

  • JIA与健康对照在初免多年后体液和细胞免疫应答相似。
  • 加强接种次数和早期时机对JIA中和抗体影响最显著。
  • JIA患者应尤其重视及时接种加强针。

核心结论

  • 无论是否患JIA,接种儿童在初免多年后针对TBEV的体液和细胞免疫相似。
  • JIA患者接受加强接种后体液免疫应答显著高于未加强者,强调及时加强的必要性。
  • 尽管免疫抑制治疗主要对TBEV特异性细胞免疫有负面影响,多数JIA患者仍产生良好的体液免疫应答并维持。

研究设计与样本

  • 研究纳入既往接种过TBE疫苗的JIA患者与健康对照,检测IgG抗TBEV亲和力、中和能力、IFNγ-ELISPOT细胞反应性和细胞因子分泌。

主要发现

  • JIA与健康对照的IgG抗TBEV抗体浓度、中和滴度和细胞反应性相似。
  • 加强接种的次数和初免后早期时机对JIA中和抗体及两组IgG抗TBEV浓度影响最显著。
  • 加强接种使JIA患者更可能达到IgG抗TBEV浓度≥165 VIEU/ml和亲和力>60%。
  • TNF-α抑制剂对体液免疫有正面作用,而甲氨蝶呤给药有负面作用。

关键数值与推荐

  • JIA患者加强接种后IgG抗TBEV浓度≥165 VIEU/ml和亲和力>60%的可能性增加。

临床怎么用

  • 对居住在高TBEV流行区的JIA患者,应确保按推荐及时接种灭活TBE疫苗加强针。
  • 接种时使用TNF-α抑制剂可能对体液免疫有利,而甲氨蝶呤可能减弱应答,需综合评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Juvenile Idiopathic Arthritis (JIA) patients living in areas with high prevalence of tick-borne-encephalitis-virus-(TBEV)-infection are recommended for administration of inactivated TBE-vaccination. However, there are serious concerns regarding protective vaccine-induced immune responses against TBEV in immunocompromised patients. The present study aimed to analyze the humoral and cellular immune response to TBE-vaccination in previously TBE-vaccinated JIA patients compared to healthy controls (HC) including investigation of IgG-anti-TBEV avidity, neutralization capacity, cellular reactivity by IFNgamma-ELISPOT and cytokine secretion assays. Similar IgG-anti-TBEV antibody concentrations, neutralization titers and cellular reactivity were found between JIA and HC. The number and the early timing of booster vaccinations after primary vaccination had the most prominent effect on neutralizing antibodies in JIA and on IgG-anti-TBEV concentrations in both JIA and HC. Administration of booster vaccinations made it more likely for JIA patients to have IgG-anti-TBEV concentrations ≥165 VIEU/ml and avidities >60%. TNF-alpha inhibitors had a positive and MTX administration a negative effect on humoral immune responses. In conclusion, irrespective of having JIA or not, vaccinated children showed similar humoral and cellular immunity against TBEV several years after primary TBE-vaccination. However, in JIA, booster vaccinations mounted a significantly higher humoral immune response than in JIA without boosters. Our results highlight the need for timely administration of boosters particularly in JIA. Although immunosuppressive treatment at vaccinations in diagnosed JIA had a negative effect mainly on TBEV-specific cellular immunity, most JIA patients mounted a favorable humoral immune response which was maintained over time. Thus, successful TBE-vaccination seems highly feasible in JIA patients with immunosuppressive regimens.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Prelog M, Almanzar G, Stern R, et al. Humoral and cellular immune response to tick-borne-encephalitis (TBE) vaccination depends on booster doses in patients with Juvenile Idiopathic Arthritis (JIA). Vaccine. 2021. PMID: 34462165. doi:10.1016/j.vaccine.2021.08.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。